FDA Boosts Affordable Access to Insulin and Biological Products
ICER, Aetion to Boost Real-World Evidence for Clinical Trials
FDA Develops Web-Based Resource to Support Pharmacogenetics
Esperion Earns FDA Approval for Cholesterol Lowering Drug Nexletol
NIH Launches Clinical Trial for Potential Coronavirus Vaccine
GSK Sells 15 Consumer OTC Products to German Pharma Company STADA
Organizations Demand Clinical Trial Coverage for Medicaid Patients
Members of Congress Demand Fair Drug Pricing for COVID-19 Vaccines
Machine Learning Supports Effective Antibiotic Discovery
International Reference Pricing Implementation Challenges
IBM Watson Unveils Cloud-Based Clinical Trial Efficiency Tech
Former Pharma Executive Pleads Guilty to Antitrust Conspiracy
HHS, J&J Partner to Boost Vaccination Discovery for Coronavirus
FDA, Indian Government Stop 500 Illicit Prescription Drug Shipments
Prescription Drug Prices Rose 21% as Utilization Remained Steady
Pharmaceutical Company Mallinckrodt Sued Over Seizure Drug Cost
CMS Launches New Billing Code for Coronavirus Testing
GoodRx Names Top 20 Most Expensive Prescription Drugs in 2020
Children’s Hospitals Team Up to Link Patients to Clinical Trials
Congress’ Think Tank Digs Into Drug Patenting Practices
Industry Backs FDA Guidance on Patient-Focused Drug Development
Machine Learning Moves the Needle on Personalized Antidepressants
HHS Launches Foundry for American Biotechnology to Spur Innovation
Chronic Disease Management Drug Shows Real-World Efficacy
Biogen Triumphs Over Patent Challenge of Multiple Sclerosis Drug
CMS Moves to Foster Access to Generics, Biosimilars in New Rule
White House Releases Drug Control Strategy for 2020
Many Antibiotics Prescribed Without ‘Clear Rationale,’ Study Says
WHO Touts Vaccines in Global Principles Against Cancer
FDA, FTC Join Forces on Biologics Competition
Opposition to International Pricing Index for Part B Drugs Mounts
FDA Breaks Down Barriers to Prioritizing Generic Drug Approvals
FDA Aims to Bolster Gene Therapy Development with New Guidance